銅陵有色(000630.SZ):資產重組事項獲深交所重組委審核通過
格隆匯6月29日丨銅陵有色(000630.SZ)公佈,公司擬向銅陵有色金屬集團控股有限公司發行股份、可轉換公司債券及支付現金購買其持有的中鐵建銅冠投資有限公司70%股權,並擬向不超過35名特定投資者發行可轉換公司債券募集配套資金。
深圳證券交易所併購重組審核委員會於2023年6月28日召開2023年第9次併購重組審核委員會審議會議,對公司發行股份、可轉換公司債券及支付現金購買資產並募集配套資金暨關聯交易的申請進行了審議。根據深圳證券交易所併購重組審核委員會發布的《深圳證券交易所併購重組審核委員會2023年第9次審議會議結果公吿》,本次會議的審議結果為:本次交易符合重組條件和信息披露要求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.